Compounds > 1-(4-methoxyphenyl)pyridinium
Page last updated: 2024-09-03

1-(4-methoxyphenyl)pyridinium and Parkinson Disease, Secondary

1-(4-methoxyphenyl)pyridinium has been researched along with Parkinson Disease, Secondary in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drobitch, R; Hagg, T; Robertson, H; Van Kampen, J1
Guerra, MJ; Labandeira-Garcia, JL; Mendez-Alvarez, E; Muñoz, A; Rey, P; Soto-Otero, R1
Forno, LS; Irwin, I; Langston, EB; Langston, JW1
López Alemany, M1

Other Studies

4 other study(ies) available for 1-(4-methoxyphenyl)pyridinium and Parkinson Disease, Secondary

ArticleYear
Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease.
    Experimental neurology, 2003, Volume: 184, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Locomotion; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Panax; Parkinson Disease, Secondary; Phytotherapy; Plant Extracts; Pyridinium Compounds; Rats; Rats, Sprague-Dawley

2003
Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
    Neuropharmacology, 2006, Volume: 51, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiparkinson Agents; Captopril; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; In Vitro Techniques; Lipid Peroxidation; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondria; Monoamine Oxidase; Neostriatum; Nerve Degeneration; Nerve Endings; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Pyridinium Compounds; Synaptosomes; Tyrosine 3-Monooxygenase

2006
Pargyline prevents MPTP-induced parkinsonism in primates.
    Science (New York, N.Y.), 1984, Sep-28, Volume: 225, Issue:4669

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Chemistry; Male; Neurons; Pargyline; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Saimiri; Substantia Nigra

1984
Parkinsonism as late toxic effect of dihydropyridines?
    Lancet (London, England), 1986, Mar-29, Volume: 1, Issue:8483

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Humans; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Time Factors

1986